Positive aspects of the mRNA platform for SARS CoV 2 vaccines
ABSTRACT The unprecedented need to acquire a safe and effective vaccine for the long term control of coronavirus disease 2019 (COVID 19) is a global imperative. Researchers have been working urgently and collaboratively to develop vaccines against the causative agent of COVID 19. The use of messenger RNA (mRNA) vaccine platform offers new opportunities for the development of effective vaccines. The first use of COVID 19 mRNA vaccines for individuals outside the clinical trials raised concerns over their safety and future efficacy. In social media, particularly in developing countries, widely shared false claims allege that the current mRNA based COVID 19 vaccines potentially integrate into the host genome and thus may genetically modify humans. These vaccines are also assumed to lack efficacy due to the emergence of new strains. Such misinformation cause people to hesitate about receiving vaccination against COVID 19. This commentary aimed to outline the structure, mechanism of action and the major motive for the use of COVID 19 mRNA vaccine, with a focus on scientifically addressing challenges associated with conspiracy theories and dispelling misinformation around vaccination.
Human vaccines immunotherapeutics